ANVISA registration

MAGLUMI Anti-HBc (CLIA)

Registration 80102512627. ANTICORPO TOTAL NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBCAG)

Registration details

Registration number80102512627
Application number25351050247202070
Technical nameANTICORPO TOTAL NUCLEAR PARA VÍRUS DE HEPATITE B (ANTI-HBCAG)
Risk classIV
Published on11/01/2021
ValidityValid until 11/01/2031

Registration holder

Legal nameVR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA
CNPJ04.718.143/0001-94

Manufacturer

  • SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. CHINA, REPÚBLICA POPULAR

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist